• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GRIFOLS DIAGNOSTIC SOLUTIONS INC. PROCLEIX ULTRIO ELITE ASSAY; HIV-1/HIV-2/HCV/HBV DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GRIFOLS DIAGNOSTIC SOLUTIONS INC. PROCLEIX ULTRIO ELITE ASSAY; HIV-1/HIV-2/HCV/HBV DEVICE Back to Search Results
Catalog Number 731770
Device Problem False Negative Result (1225)
Patient Problem Insufficient Information (4580)
Event Date 03/07/2023
Event Type  Injury  
Event Description
On (b)(6) 2023, grifols customer creative testing solutions (cts, florida) reported one organ donor sample (b)(6) that was nonreactive (s/co 0.06 ) with ultrio elite (ue) ml 704640 and reactive (s/co 24.71) in the ultrio elite hbv discriminatory assay (dhbv).It was nonreactive in the discriminatory hiv and discriminatory hcv assays (s/cos 0.05 and 0.00, respectively).The site testing protocol is to test ue and discriminatory assays simultaneously due to time constraints.If ue is nonreactive, their protocol is to cancel discriminatory testing.In this case, they did not follow their protocol.No sample volume is available for investigation.Relevant tests/laboratory data, including dates.(b)(6) 2023: sample (b)(6) ultrio elite nonreactive (s/co 0.06).(b)(6) 2023: sample (b)(6) dhiv invalid.(b)(6) 2023: sample (b)(6) dhcv nonreactive (s/co 0.00).(b)(6) 2023: sample (b)(6) dhbv reactive (s/co 24.71).(b)(6) 2023: sample (b)(6) dhiv nonreactive (s/co 0.05).Investigation.The following additional information was requested, and customer is unwilling/ unable to provide responses: was the organ donor heart beating or non-heart beating? what was the sample type (matrix)? was the sample diluted? was the organ donation released? are other test results available (serology, pcr, other nat)? risk assessment.Panther assay specific risk analysis for bloodbank assays, rsk-00854 rev.011 and product safety risk management procedure, 04-03-12-sop version 9.0 were reviewed to assess risk.New risk to patient safety was not identified.There were no related nonconformances noted in the manufacturing record or as part of a search of the nonconformance records for this lot number.Product impact: no impact to product was identified.Review of the qc release data and a previous events search in the grifols complaint system indicate that the assay is working as designed.Customer impact: the impact to the customer was questioning the ultrio elite results and their testing protocol.It is unknown if the donation was used.Following iso 14971, grifols risk assessment is based on severity of a harm or impact to human health and the probability of occurrence of harm or impact to human health.Based on the severity rating of critical·and probability rating of remote·, the overall risk posed by a false negative ultrio elite result is determined to be acceptable.Root cause: due to a lack of sample for investigation and lack of information available, the root cause of the nonreactive ue result cannot be determined.A review of the quality control data for ultrio elite ml 704640 was performed.There were no related quality events found for this lot/batch of product and the product met all release criteria.The previous events search showed no indication of hbv sensitivity issues with ml 704640.All available information indicates the ultrio elite assay is working as designed.This is the final report and no additional information is expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROCLEIX ULTRIO ELITE ASSAY
Type of Device
HIV-1/HIV-2/HCV/HBV DEVICE
Manufacturer (Section D)
GRIFOLS DIAGNOSTIC SOLUTIONS INC.
4560 horton street
emeryville CA 94608
Manufacturer Contact
jin shi
10808 willow ct
san diego, CA 92127
8582020806
MDR Report Key16690950
MDR Text Key312794407
Report Number2032600-2023-00003
Device Sequence Number1
Product Code QHO
UDI-Device Identifier00859882007665
UDI-Public00859882007665
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BL125652
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/15/2023
Device Catalogue Number731770
Device Lot Number704640
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-